Schroder Investment Management Group
SPPI

Schroder Investment Management Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Schroder Investment Management Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-596,781
Closed -$4.45M – 1647
2013
Q2 		$4.45M Buy
+596,781
New +$4.58M 0.01% 775

Other funds holding SPPI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCAM
F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group's SPPI Position: Q3 2013 in Review

Schroder Investment Management Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2013, closing a stake of 596,781 shares — an estimated $4.45M sold.

Schroder Investment Management Group first reported a position in SPPI in Q2 2013 and held it in 1 quarter. The position peaked at $4.45M in Q2 2013. 118 funds tracked by Wall St. Rank hold SPPI as of Q3 2013.

  • Schroder Investment Management Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • Schroder Investment Management Group sold 596,781 Spectrum Pharmaceuticals Inc shares in Q3 2013, an estimated $4.45M.
  • Schroder Investment Management Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • Schroder Investment Management Group's Spectrum Pharmaceuticals Inc position peaked at $4.45M in Q2 2013.
  • 118 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2013.

Based on Schroder Investment Management Group's 13F filing for Q3 2013, filed 8 Nov 2013.